ArticleBMC cancer2017

Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis.

Dan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.